<DOC>
	<DOCNO>NCT03100591</DOCNO>
	<brief_summary>The primary purpose study investigate rate route ( urine feces ) elimination ACT-132577 , mass balance urine feces</brief_summary>
	<brief_title>A Study Evaluate ACT-132577 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Signed informed consent language understandable subject prior studymandated procedure ; Healthy male subject age 45 65 year ( inclusive ) screening ; Body mass index 18.0 28.0 kg/m2 ( inclusive ) screening ; Healthy basis physical examination , cardiovascular assessment laboratory test . Values hepatic aminotransferase ( alanine aminotransferase and/or aspartate aminotransferase ) &gt; 3 × upper limit normal range screening ; Hemoglobin &lt; 100 g/L screening ; Known hypersensitivity ACT132577 drug class , excipient ACT132577 drug formulation ; Known hypersensitivity allergy natural rubber latex ; Previous exposure ACT132577 ; Treatment another investigational drug within 3 month prior screen participation 4 investigational drug study within 1 year prior screen ; Any circumstance condition , , opinion investigator , may affect full participation study compliance protocol ; A radiation burden &gt; 0.1 milliSievert ( mSv ) ≤ 1.0 mSv period 1 year prior screening ; radiation burden ≥ 1.1 mSv ≤ 2.0 mSv period 2 year prior screen , etc . ( add 1 year per 1 mSv ) .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>